Latest MSD News & Updates

See the latest news and media coverage for MSD. We track all announcements, press releases, and industry mentions in real time, all in one place.

MSD

Research-intensive biopharmaceutical company

msd.com

Headquarters: Rahway, United States
Company type: Public company
Number of employees: 35,000+

Last updated Today

Latest news about MSD

In short: MSD achieved positive Phase III results for tulisokibart in ulcerative colitis and expanded its oncology pipeline through the acquisition of Terns.

Company announcements

Yesterday MSD

MSD's tulisokibart met Phase 3 UC trial endpoints

The anti-TL1A antibody achieved clinical remission at 12 weeks in patients with moderately to severely active ulcerative colitis, with no safety concerns identified.

May 8 MSD

MSD states no material impact from Daiichi Sankyo's manufacturing update

MSD remains confident in their ADC collaboration's multibillion-dollar opportunity. Daiichi Sankyo handles manufacturing for most ADCs; MSD for gocatamig.

May 7 MSD

MSD scientists publish paper on biocatalytic synthesis of enlicitide decanoate

The Science publication details a scalable enzyme-based method for producing the investigational oral PCSK9 inhibitor, offering sustainability and manufacturing efficiencies.

May 5 MSD

MSD completes acquisition of Terns Pharmaceuticals

The deal adds TERN-701, an investigational BCR::ABL1 inhibitor for chronic myeloid leukemia, to MSD’s oncology pipeline. Transaction valued at $5.8 billion.

Media coverage

Today Yahoo

MSD’s anti-TL1A mAb from $10.8bn acquisition wins in Phase III trial

MSD’s investigational humanised monoclonal antibody targeting tumour necrosis factor-like cytokine 1...

Yesterday Las Vegas Sun

Merck’s Tulisokibart Met Primary and Key Secondary Endpoints in the Phase 3 ATLA...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced positive topline results from the Phase 3 ATLAS-UC induction-only study...

June 18 The National Law Review

U.S. FDA Approves an Additional Indication for CAPVAXIVE® (Pneumococcal...

RAHWAY, N.J.--(BUSINESS WIRE)--$MRK #MRK--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the U.S. Food and Drug Administration...

June 15 Medical Xpress

FDA expands use of kidney cancer drug belzutifan

Belzutifan, a first-in-class drug that arose from scientific discoveries at UT Southwestern Medical Center, has been approved by the Food and Drug Administration to treat...

Never miss news about MSD

Track MSD and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

MSD competitors & trending companies

Browse news for competitors to MSD and other trending companies.